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Abstract
Carrageenan (CGN) is a high molecular weight sulphated polysaccharide derived from red seaweeds. In rodents, its
degraded forms (dCGN) can induce intestinal inflammation associated with macrophage recruitment and activation. The
aim of this study was: 1) to analyze the size-dependent effects of dCGN on colon inflammation in vivo, and 2) to correlate
these effects with monocyte/macrophage proliferation, cytokine production and expression of various cell surface antigens
including ICAM-1 adhesion molecule. Peripheral blood monocytes (PBM) and THP-1 monocytic cells were cultured in the
presence of either 10 or 40 kDa, dCGN. The 40 kDa, but not the 10 kDa dCGN, induced colitis in in vivo. Degraded CGN
inhibited THP-1 cell proliferation in vitro, arresting the cells in G1 phase. In addition, dCGN increased ICAM-1 expression in
both PBM and THP-1 cells with a major effect seen after 40 kDa dCGN exposure. Also, dCGN stimulated monocyte
aggregation in vitro that was prevented by incubation with anti-ICAM-1 antibody. Finally, dCGN stimulated TNF-a
expression and secretion by both PBM and THP-1 cells. All these effects were linked to NF-kB activation. These data strongly
suggest that the degraded forms of CGN have a pronounced effect on monocytes, characteristic of an inflammatory
phenotype.
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Introduction
Carrageenan (CGN) is a high molecular weight sulphated
polysaccharide (.200 kDa) derived from red algae (Rhodophyceae).
Three main forms of CGN have been identified: kappa, iota, and
lambda. They differ from each other in sulphation degree and
solubility [1,2]. Native CGN is thought to be harmless and is
widely used as a food additive to improve texture. It is also used in
cosmetics and pharmaceuticals. However, acid treatment at high
temperature (80uC) triggers CGN hydrolysis to lower molecular
weight (,50 kDa) compounds known as poligeenan or degraded
CGN (dCGN). These dCGNs induce inflammation and have been
widely used as models of colitis in several species, including rats
[3], rabbits [4] and guinea pigs [5]. The role of dCGN as a tumor-
promoting factor remains controversial [4,6–8].
Although the native form is thought to be harmless for human
consumption, small amounts of dCGN are probably produced by
acid hydrolysis during gastric digestion [9,10] or interaction with
intestinal bacteria [11,12]. Whereas the effects of native and
dCGN on intestinal inflammation have been extensively analyzed
in animal models, only few studies have been conducted using
human cell lines. Recent studies have shown a link between
exposure to native form CGN and IL-8 production by the human
intestinal epithelial cell line, NCM460, via Nuclear Factor-kB (NF-
kB) activation [13,14]. NF-kB is a transcription factor that
regulates the expression of genes associated with inflammation
[15,16].
Macrophage infiltration and accumulation is a common
characteristic of intestinal diseases [17]. Macrophages represent
10% of total lamina propria cells, secrete a wide range of biologically
active compounds and express cell-adhesion molecules. The
immune cell response to an inflammatory stimulus seems to be
amplified or directly generated by cells exposed to sulphated
polysaccharides such as carrageenans. Indeed, inflammation
induced by dCGN was associated with recruitment of macro-
phages to inflammation sites [18,19]. Also, inflammation induced
by Dextran Sulphate Sodium (DSS), another sulphated com-
pound, was directly associated with macrophages recruitment
[20], since DSS still provoked inflammation after T-lymphocyte
and NK cell depletion [20]. Although inflammation can be
PLoS ONE | www.plosone.org 1 January 2010 | Volume 5 | Issue 1 | e8666induced by dCGN, there are no data on human monocyte
responses to dCGN exposure. Therefore, to investigate the effects
of dCGN on human monocytes, normal Peripheral Blood
Monocytes (PBM) and tumoral monocyte/macrophage THP-1
cells were exposed to 10 kDa and 40 kDa dCGN. We found that
dCGN inhibited THP-1 cell proliferation in vitro, increased ICAM-
1 expression, stimulated ICAM-1-dependent monocyte aggrega-
tion, and stimulated TNF-a expression and secretion. These
responses were more pronounced after 40 kDa dCGN exposure
and were linked to NF-kB activation. In addition, the 40 kDa
dCGN, but not the 10 kDa dCGN induced in vivo colitis as shown
by the inflammatory response in the rat colon. These results
suggest that the degraded forms of CGN have an important effect
on monocytes resulting in an inflammatory phenotype.
Materials and Methods
Preparation of Degraded Carrageenan
Two preparations of degraded carrageenan with low, (,10
kDa; C10), and medium, (,40 kDa; C40) molecular weight were
prepared from native iota-carrageenan extracted from Euchema
spinosum (generously provided by Sanofi Biosystems Industry,
Boulogne-Billancourt, France). Native carrageenan was dissolved
in distilled water (5% w/v) under vigorous stirring and heated to
60uC. Then, the carrageenan solution was submitted to two
different treatments to obtain both low and medium molecular
weight fractions. Briefly, for the low molecular weight fraction,
carrageenan solution was hydrolyzed with 0.3% (v/v) concentrat-
ed sulphuric acid for 15 min at 80uC. After neutralization with
NaOH 4N, the solution was ultra filtered through a hollow fibre
cartridge with MW cut-off 5 kDa, (Amicon Inc, Beverly, USA).
For the medium molecular weight fraction, the carrageenan
solution was hydrolyzed with 0.3% (v/v) concentrated sulphuric
acid for 30 min at 60uC. After neutralization, the supernatant was
ultra filtered (MW cut-off 100 kDa). The filtrate was submitted to a
second ultra filtration (MW cut-off 5 kDa). Both preparations of
dCGN were precipitated with 4 volumes of 95% ethanol, dried at
room temperature and ground to small particles (1 mm in
diameter). Using gel-permeation chromatography in combination
with light scattering measurements (see Viebke et al. [21]), it was
confirmed that the low fraction had an average molecular weight
of 10 kDa, and the medium fraction of 40 kDa. The sulphate
content of polysaccharides in both fractions was measured
following the method of Quemener et al. [22]. Finally, the
absence of polysaccharide structure modifications in the two
fractions was confirmed using
2H-NMR spectroscopy. The
absence of LPS contamination in the two fractions was confirmed
using the e-Toxate
H kit (Sigma, St Quentin Fallavier, France).
Before use in cell culture, the two fractions were dissolved in
complete medium during 30 min at 56uC.
Animals, Chemicals and Diet
Male Wistar rats (150 g average weight) were housed under
standard conditions and fed ad libitum with standard rodent
laboratory chow. Degraded iota-carrageenans were administered
in the drinking water (5% w/v) for 55 days to 2 groups of six
animals each. The first group received the low molecular weight
carrageenan (10 kDa dCGN) and the second received the medium
molecular weight carrageenan (40 kDa dCGN). An additional
group of four rats were maintained on regular tap water (control
group). To increase palatability 0.2% sucrose was added to the
drinking water of all groups (Van der Waaji et al., [23]). Fresh
carrageenan solutions were prepared daily.
Evaluation of Colitis
Body weight, liquid and food consumption, diarrhea and rectal
bleeding (detected by eye inspection) were recorded throughout
the feeding period. After 55 days, animals were sacrificed by
cervical dislocation. The length of the colon was measured as
described by Okayashu et al. [24]. Then, each colon was ligated in
sections of 2 cm and 1 to 2 ml of 10% formalin was infused into
the intestinal lumen. The moderately distended segment was
sectioned and fixed in 10% formalin. The following day, the
intestinal content was removed by vortexing. The fixed segment
was kept in 10% formalin at 4uC until the paraffin embedding
procedure. To evaluate the degree of inflammation, this segment
of colon was opened longitudinally and macroscopic and
histological scores of inflammation were recorded as previously
described [25,26]. The toluidine blue staining was used for
identification of sulphated polysaccharides in the intestinal
mucosa. On the day of sacrifice, a fresh sample of each colon
(50 mg) was collected for myeloperoxidase (MPO) assay according
to Krawisz et al., [27]. The level of MPO, mainly expressed by
neutrophils, indicates the rate of recruitment of neutrophils to the
intestinal mucosa. One unit of MPO activity corresponds to the
degradation of 1 mmol of peroxide per minute at 25uC.
Cell Culture
All tissue culture reagents were from Invitrogen (Cergy
Pontoise, France). THP-1 human monocytic cells were maintained
in RPMI-1640 supplemented with 10% FCS, 2 mM L -glutamine,
50 U/ml penicillin and 50 mg/ml streptomycin at 37uCi na5 %
CO2 incubator. Human peripheral blood mononuclear cells were
obtained from heparinized blood by Ficoll-Hypaque density
gradient. Monocytes were then isolated by adherence to culture
flasks as described [28]. For cell aggregation, monocytes were
cultured in the presence or absence of C10 or C40 for 72 h. Cell
colonies were monitored under an inverted phase contrast
microscope coupled through a video camera to a computer. In
some wells, neutralizing monoclonal antibody to ICAM-1 (2.5 mg/
ml) (Tebu, Le Perray en Yvelines, France) was added.
Cell Cycle Analysis
THP-1 cells in exponential growth phase were exposed to
complete medium in the presence or absence of carrageenans for
24 h before being stained with propidium iodide using the DNA-
Prep Coulter kit according to the manufacturer’s instruction
(Beckman-Coulter, Villepinte, France). Cell DNA content was
then analyzed by flow cytometry using an EPICS XL2 (Beckman-
Coulter). Raw data for the distribution of DNA content of 30,000
cells retrieved from the cytometer were expressed as the
percentage of G0/G1 through G2/M populations. Multicycle
AV software (Phoenix Flow Systems, San Diego, CA) was used to
generate DNA content frequency histograms and facilitate data
analysis.
Cell Surface Antigen Expression Analysis
Peripheral Blood Monocytes or THP-1 cells were exposed to
complete medium in the presence or absence of carrageenan for
36 h. After two washes in PBS without Ca
2+ and Mg
2+, cells were
incubated in PBS containing 0.1% gelatin and 8% AB human
serum to prevent binding to Fc receptors. Then, 5610
5 cells were
incubated with primary antibodies at 4uC for 30 min. Two other
washes in PBS preceded incubation with FITC-conjugated goat
antibody anti-mouse IgG diluted 1/1000 at 4uC for 30 min
(Tebu). After two additional washes, analysis of stained cells was
performed on an EPICS XL2 (Beckman-Coulter). The cell
Carrageenan Activates Monocyte
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scattering. Data were expressed as mean relative fluorescence
intensity (MFI) of 3000 cells.
TNF Activity Bioassay
Monocytes or THP-1 cells were cultured with or without
different concentrations of CGNs or LPS (Salmonella typhosa, Sigma)
for 24 h or the indicated time. Biologically active TNF-a/b in
tissue culture supernatant was measured using the WEHI 164
clone 13-cell killing assay [29]. TNF concentrations are expressed
as pg/ml.
RT-PCR Analysis
Total RNA from monocytes was isolated using TRIzol
Reagent
TM (Invitrogen). cDNA was generated on 1 mg of total
RNA in a reaction volume of 20 ml, using M-MLV reverse
transcriptase (Invitrogen). PCR was done in the linear range of
amplification (determined for each primer pair-cDNA combina-
tion). Standard PCR reactions were performed with 1 ml of the
cDNA solution, 50 mM of each primer solution, 10 mM of each
dNTP, 25 mM MgCl2, 10X Goldstar DNA polymerase reaction
buffer, and 0.5 units of Goldstar DNA polymerase (Eurogentec,
Seraing, Belgium). First PCR cycle consisted of 1 min at 92uC, 1
min at 58uC and 1 min at 72uC; then each PCR cycle consisted of
40 sec at 92uC, 40 sec at 58uC and 50 sec at 72uC. cDNA for b-
actin was amplified for 28 cycles using the oligos: sense 59-
GGCATCGTGATGGACTCCG-39 and antisense 59GCTGGA-
AGGTGGACAGCGA-39. cDNA for TNF-a was amplified for 35
cycles using the oligos: sense 59-AAGCCTGTAGCCCATGT-
TGT-39 and antisense 59-CAGATAGATGGGCTCATACC-39.
cDNA for ICAM-1 was amplified for 35 cycles using the oligos
sense 59-GTAGCAGCCGCAGTCATAATGG-39 and antisense
59-A TGCTGTTGTATCTGACTGAGG-39.
NF-kB Transcription Reporter Gene Assay
The plasmid 3XMHC-luc (a generous gift from Drs. J.
Westwick and D.A. Brenner, University of North Carolina,
Chapel Hill) contains three copies of NF-kB-responsive element
from the MHC class I locus, placed upstream of the luciferase
gene. Human monocytic THP-1 cells were transiently transfected
as previously described [30], and then cultured for 4 h alone or
with increasing concentration of either C10 or C40. Luciferase
activity was determined using a luminometer (Monolight 2010
Luminometer, Ann Arbor, MI).
Western Blot Analysis
THP-1 cells were stimulated for various lengths of time with 0.1
mg/ml C10 or C40, or 10 mg/ml LPS. Cells were then pelleted,
washed and homogenised in lysis buffer (10 mM Hepes, pH 7.9,
150 mM NaCl, 1 mM EDTA, 0.6% NP-40, and 0.5 mM PMSF)
on ice. Homogenates were sonicated, centrifuged at 10,000 rpm to
remove cellular debris, and supernatant collected. Protein
concentration was determined using the DC Protein Assay (Bio-
Rad). Proteins in samples (15 mg total proteins) were resolved in a
denaturing 12% polyacrylamide gel and transferred to a
nitrocellulose membrane. I-kBa protein was detected using a
rabbit polyclonal antibody (Santa Cruz Biotechnology, CA)
followed by a horseradish peroxidase-coupled goat polyclonal
antibody against rabbit Ig (Caltag Laboratories). Finally, IkB
bands were revealed using the ECL
TM detection system
(Amersham Pharmacia Biotech, Les Ullis, France) according to
the manufacturers’ instruction. Antibody to a-Tubulin (Santa
Cruz) was use as loading control.
For nuclear NF-kB, THP-1 cells were stimulated with 1 mg/ml
C10 or C40 for 30 minutes at 37uC. Cells were then pelleted and
nuclei separated as described [31]. Nuclei were washed and
homogenized directly in loading (Laemli) buffer and heated for 5
minutes at 100uC. Proteins in samples were resolved in a denaturing
8% polyacrylamide gel and transferred to a polyvinylidine fluoride
(PVDF) membrane (Immobilon-P; Millipore, Bedford, MA).
Membranes were incubated in blocking buffer (1% BSA, in PBS)
for two hours at room temperature. Membranes were subsequently
probed with the corresponding antibody in blocking buffer,
overnight. Rabbit polyclonal antibody anti-NF-kB p50 subunit (#
sc-114) or anti-NF-kB p65 subunit (# sc-109) from Santa Cruz
Biotechnologywereused.MembraneswerewashedsixtimesinPBS
with 0.05% Tween 20, 5 minutes each time, and incubated with a
1/3000 dilution of HRP-conjugated F(ab’)2 goat anti-rabbit IgG in
5%nonfatdry milk and0.05% Tween 20 inPBS for 1 hour atroom
temperature. After washing six more times in PBS with 0.05%
Tween 20, antibody-reactive proteins were detected using a
chemiluminescence substrate (SuperSignal; Pierce, Rockford, IL)
according to the manufacturer’s instructions. To confirm that
equivalent amounts of protein were loaded in each line, membranes
were also Western blotted for ERK as described [32].
Analysis of NF-kB Activation by Flow Cytometry
Nuclear activation of NF2kB by flow cytometry was performed
as described [31].
Statistical Analysis
The results were expressed as the mean value 6 S.E.M. of
individual experiments. The statistical significance of the differ-
ences between mean values was assessed by the Student’s t-test and
analysis of variance (ANOVA).
Results
Degraded CGN Induce Colonic Inflammation
All rats developed diarrhea during degraded carrageenan
administration and gross evidence of blood was frequently detected
in the stools. Colon length dramatically decreased in all treated rats
witha morepronounced effectbeing observed in the 40 kDa dCGN
treated group (Fig. 1A). Furthermore, prolonged exposure to 40
kDa dCGN resulted in high macroscopic and histological scores of
inflammation (Fig. 1B, C). Only weak myeloperoxidase activity was
detected in both control and dCGN-treated groups (Fig. 1D),
indicating that granulocytes did not play a major role in the
inflammation at that stage. Histological examination revealed
various degrees of mucosal inflammation. Rats treated with 10 kDa
dCGN showed edema, epithelium atrophy and slight lymphocyte
infiltration (data not shown). These symptoms were totally absent in
the colon of control rats (Fig. 1E). More severe mucosal injuries
including ulceration, hyperplastic epithelium, crypt distortion and a
strong macrophage infiltration, were observed in the 40 kDa
dCGN-treated rats (Fig. 1F). No sulphated polysaccharides were
detected bytoluidinebluestainingofcolonmucosafromratstreated
with either the 10 or 40 kDa dCGN (not shown). Although we
cannot exclude that dCGN mat not have retained in the section
during the histology procedure, this indicates that these polymers
may not have been phagocytosed.
Degraded CGN Induced-TNF-a Production by Monocytes
In Vitro
In order to study the capacity of dCGN to stimulate TNF-a
production, peripheral blood monocytes were cultivated in the
presence of dCGN (0.1 to 1 mg/ml). Very low levels of TNF-a were
Carrageenan Activates Monocyte
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Addition of 0.1 mg/ml 10 kDa dCGN resulted in approximately a
60-fold increase in TNF-a production by PBM. This was a dose-
dependent effect that reached a 180-fold increase when cells were
exposed to 1 mg/ml of 10 kDa dCGN (Fig. 2A). A 250-fold increase
in TNF-a production was detected at 1 mg/ml 40 kDa dCGN
(Fig. 2A). TNF-a production increased in time reaching a maximum
level at 8 hours of culture (Figure 2B). After 24 h, the amount of
secreted TNF-a was still one third of the total TNF-a.L i p o p o l y -
saccharide (LPS), a known activator of immune cells also induced
TNF-a production with similar kinetics as dCGN (Fig. 2B).
However, the amount of TNF-a produced by LPS was 4-fold less
than the one produced by dCGN and it was not detected after 8
hours of culture (Fig. 2B). Similarly, monocytic THP-1 cells
cultivated in the presence of variable concentration of dCGN
showed an increase in TNF-a production (Fig. 2C). This increase in
TNF-a production was significantly smaller (about 10-fold) than the
one presented by PBM (Fig. 2A). No TNF-a was released from
THP-1 cells exposed to native CGN (not shown). TNF-a production
by THP-1 cells was not dose dependent to the amount of dCGN
used. Also there was no difference between the two forms (10 and 40
kDa) of dCGN (Fig. 2C). Interestingly, TNF-a release from THP-1
cells stimulated with dCGN reached a maximum level at 32 h, while
stimulation with LPS reached a maximum level at 56 h (Fig. 2D).
Effect of Native and Degraded CGN on THP-1
Proliferation and Cell Cycle
Preliminary observations by enumeration of THP-1 cells
exposed to different concentrations of native and dCGN (10 and
40 kDa) during 2, 5 and 7 days, showed a decline in cell number
(data not shown). This suggested that dCGN might cause an
alteration in the cell cycle. Cell cycle analysis using flow cytometry
showed an accumulation of THP-1 cells in G0/G1 phase, which
was associated with a decrease number of cells in the S phase
(Fig. 3A). The percentage of cells in the G0/G1 phase was 45.2%
for control cells, 62.6% for C10 dCGN (at 2 mg/ml), and 64.2%
for C40 dCGN-treated cells (at 2 mg/ml) (Fig. 3B). The effect of
dCGN on cell cycle was dose-dependent (Fig. 3B). Neither native
nor dCGN had an effect on the number of cells in the G2/M
phase (Fig. 3). This effect is not due to cytotoxicity of dCGN even
at the highest concentration (i.e. 2 mg/ml) since cell viability was
not affected (data not shown).
ICAM-1 Expression Is Induced by Degraded CGN and Is
Responsible for Monocytes Aggregation In Vitro
In order to study the effect of dCGN on the expression of cell
surface antigens, PBM and THP-1 cells were incubated for 36 h in the
presence and absence of dCGN. The expression of various cell surface
molecules was analyzed by flow cytometry as described in materials
and methods. Both forms of dCGN clearly stimulated expression of
ICAM-1 (CD54) on PBM and THP-1 cells (Fig. 4A). The increase in
ICAM-1 expression was higher on THP-1 cells treated with 40 kDa
dCGN (Fig. 4B). Another surface antigen, the lymphocyte function-
associated antigen 3 (CD58) was slightly reduced on PBM after
treatment with 40 kDa dCGN (Fig. 4B). Interestingly, expression of
major histocompatibility complex molecules of class I (HLA-ABC)
and of class II (HLA-DR), as well as the monocyte marker CD14,
seemed to be reduced by treatment with dCGN (Fig. 4B). However,
these differences were not statistically significant.
Treatment with dCGN also induced a strong aggregation of
monocytes, detected by phase contrast inverse microscopy (Fig. 5).
Although this effect was easily observed in monocytes incubated
with the 10 kDa dCGN (Fig. 5B), a more robust cell aggregation
was observed in monocytes incubated with the 40 kDa dCGN
(Fig. 5C). ICAM-1 has been proposed to be the main adhesion
molecule responsible for monocyte aggregation. To confirm this,
monocytes were incubated with both types of dCGN in the
presence of an anti-ICAM-1 antibody, an anti-CD58 antibody and
Figure 1. Degraded CGN induced colon inflammation in rats. Histograms showing the effect of degraded CGN on: colon length (A);
macroscopic (B) and histological (C) inflammation score of colon; Myeloperoxidase (MPO) activity (D). Control rats (white bars); 10 kDa degraded
CGN-treated rats (grey bars); 40 kDa degraded CGN-treated rats (black bars). * p,0.05 from control. ** p,0.01 from control. Histological analysis of
colon from control rats (E), and from 40 kDa dCGN-treated rats (F).
doi:10.1371/journal.pone.0008666.g001
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effectively blocked the cell aggregates induced by dCGN (Fig. 5D,
5E), strongly suggesting that indeed ICAM-1 is responsible for
monocyte aggregation. Both the control IgG1 and the anti-CD58
antibody did not modify monocyte aggregation (data not shown).
Degraded CGN Induce an Increase in ICAM-1 and TNF-a
mRNA Expression
The increase in surface ICAM-1 expression and TNF-a
production by monocytes correlated with an upregulation of mRNA
for these molecules. Both 10 kDa and 40 kDa dCGN induced a
robust increase in mRNA for both ICAM-1 and TNF-a (Fig. 6). b-
actin mRNA levels were not affected by dCGN treatment.
Degraded CGN Induce IkB Degradation and NF-kB
Activation
The expression of genes encoding for ICAM-1 and TNF-a is
controlled by the nuclear factor NF-kB. Site-specific phosphoryla-
tion of the inhibitor IkB leads to its degradation by proteasome and
to a consequential activation of the NF-kB pathway. Using a
reporter plasmid for NF-kB activation, it was confirmed that dCGN
induced a strong activation of NF-kB, as reflected by an increase in
luciferase activity (Fig. 7A). Both forms of dCGN used induced NF-
kB activation in a dose dependent manner. However, the effect was
more strongly induced by the 40 kDadCGN (Fig. 7A). These results
were further confirmed by directly detecting NF-kB in the cell
nucleus by Western blotting (Fig. 7C)and by FACS (Fig. 7D). These
assays also allowed us to determine what NF-kB subunits were
activated by dCGN. Both forms (10 or 40 kDa) of dCGN induced
activation of the p50 and p65 subunits of NF-kB. This nuclear
factor was present in low levels in the cell nucleus and increased
considerably after treatment with dCGN. Western blots suggested
the the 40 kDa form of dCGN induced a stronger activation of NF-
kB (Fig. 7C). A more sentive assay for nuclear factor activation is
flow cytometry of nuclei stained with specific antibodies for the
nuclear factor of interest. In agreement with the previous data,
FACS analysis of nuclei from THP-1 cells showed that there was a
basal level of nuclear NF-kB (Fig. 7D). Again, both forms (10 or 40
kDa) of dCGN induced an increase of the p50 and p65 subunits of
NF-kB in the nucleus of these cells. The 40 kDa degraded CGN
gave a stronger increase of NF-kB (Fig. 7D). These data strongly
Figure 2. Degraded CGN stimulated TNF secretion from monocytes. Levels of TNF released from peripheral blood monocytes (A–B) and
THP-1 cells (C–D) after stimulation with dCGN. A: TNF release induced by native CGN (open bars), 10 kDa dCGN (grey bars), or 40 kDa dCGN (black
bars). B: Kinetics of TNF release induced by nothing (control; black diamonds), 0.1 mg/ml 10 kDa dCGN (black triangles), 0.1 mg/ml 40 kDa dCGN
(black squares), or 10 mg/ml LPS (open squares). C: TNF release induced by nothing (control; open bars), 10 mg/ml LPS (hatched bars), or increasing
concentrations of 10 kDa dCGN (grey bars), or 40 kDa dCGN (black bars). D: Kinetics of TNF release induced by nothing (control; black diamonds),
0.1 mg/ml 10 kDa dCGN (black triangles), 0.1 mg/ml 40 kDa dCGN (black squares), or 10 mg/ml LPS (open squares).
doi:10.1371/journal.pone.0008666.g002
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activated by degraded CGN in monocytes. In addition, degradation
of the inhibitor IkBa was also observed in cells treated with dCGN
(Fig. 7B). No significant IkBa degradation was detected within two
hours of dCGN treatment, but IkBa was markedly degraded by
four hours of dCGN treatment (Fig. 7B). We focused on IkBa
subunit, since it masks the nuclear localisation sequence of p65, it is
the most rapidly degraded subunit and the most studied one.
Discussion
Inflammation of the intestinal tract is usually associated with
infiltration and activation of intestinal macrophages [17]. These
macrophages are able to initiate immune responses and can be
induced to differentiate into cells that either exacerbate or inhibit
the inflammation. Accumulation of different types of leukocytes,
including monocytes/macrophages, neutrophils, and lymphocytes
in the intestinal mucosa during inflammation, is normally followed
by secretion of pro-inflammatory cytokines [33]. Several stimuli
can induce these leukocytes to produce and secrete cytokines
during inflammation. One of the most potent and known stimuli
for leukocyte activation is LPS from Gram-negative bacteria [34].
In addition, other factors are also able to stimulate cytokine
secretion from various leukocytes [35,36]. One such factor is
CGN, a high molecular weight sulphated polysaccharide (.200
kDa) derived from red algae (Rhodophyceae) [1,2]. Native CGN is
Figure 3. Degraded CGN induced THP1 cell cycle arrest in G1 phase. THP-1 cells in exponential growth phase were incubated in the
presence or absence of carrageenan for 24 h before being stained with propidium iodide. Cell DNA content was then analyzed by flow cytometry. A:
Histograms of cells treated with medium only (control), 10 kDa dCGN (C10), or 40 kDa dCGN (C40). B: Percentage of cells in each phase of the cell
cycle when treated with medium only (control), different concentrations of 10 kDa dCGN (C10), of 40 kDa dCGN (C40), or of native CGN (Native).
doi:10.1371/journal.pone.0008666.g003
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used in cosmetics and pharmaceuticals. Although native form
CGN (200–800 kDa) has been declared harmless to humans [8],
its degraded forms (,50 kDa), also known as poligeenan, are
widely used to induce colitis in rodents [3–5]. These degraded
CGN may also have a possible carcinogenic effect [4,6–8];
however this is still controversial.
Although acid treatment at high temperature (80uC) is required
for CGN hydrolysis in vitro to lower molecular weight dCGN, it is
probable that some dCGN are produced by acid hydrolysis during
gastric digestion [9,10] or interaction with intestinal bacteria
[11,12]. Thus, understanding the mechanisms of dCGN-induced
bowel inflammation is of great importance. In this report, we have
analyzed the role of human monocytes (PBM and THP-1) in
dCGN-induced inflammation.
Preliminary in vivo studies in rats treated with dCGN revealed
significant shortening of the large intestine associated with an
inflammatory state, i.e. strong infiltration of macrophages to the
Figure 4. Degraded CGN stimulated ICAM-1 expression in monocytes. Peripheral blood monocytes (PBM) or THP-1 cells were incubated in
the presence or absence of carrageenan for 24 h before being stained for various cell surface antigens. Antigen expression was then analyzed by flow
cytometry. A: Histograms of ICAM-1 expression in cells treated with medium only (control), 10 kDa dCGN (C10), or 40 kDa dCGN (C40). B:
Fluorescence intensity for expression of the antigens HLA-ABC, HLA-DR, CD14, ICAM-1, and CD58 in cells treated with medium only (control), 10 kDa
dCGN (C10), or 40 kDa dCGN (C40). Data are mean +/2 SEM.
doi:10.1371/journal.pone.0008666.g004
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Using two fractions of dCGN (10 and 40 kDa), we observed a
strong correlation between the severity of the inflammation and
the dCGN molecular size, thus confirming the size related
inflammation in vivo. This macrophage accumulation was not
due to cell proliferation because dCGN inhibited THP-1
monocytes proliferation in vitro. These results are similar to those
obtained with human colonic epithelial cells (NCM460 cell line)
exposed to native CGN for 1–8 days [37]. Thus, it seems that
dCGN promote macrophage infiltration by recruiting new cells to
the inflamed intestinal mucosa and not by inducing cell
proliferation. In addition, very few polymorphonuclear cells were
detected in the mucosa at the time point analyzed as demonstrated
by a very low level of MPO in the intestinal tissue.
These results suggest that monocytes might produce cytokines
associated with activation into macrophages in response to dCGN.
Thus, we analyzed the production of TNF by both PBM and
THP-1 cells in response to dCGN. Degraded CGN induced a
robust production of TNF by monocytes. The 40 kDa form of
dCGN was more potent for monocyte stimulation than the 10 kDa
or the native ones. Surprisingly, monocyte activation by dCGN to
produce TNF was much stronger than the activation induced by
LPS, an inflammatory factor considered to be among the most
potent stimuli for leukocyte activation. These results underline the
fact that partially degraded forms of CGN have important cellular
effects. The amount of TNF secreted by PBM induced with LPS
was much larger than the one secreted by THP-1 monocytes.
Since monocyte activation by LPS is associated with the presence
of the CD14 and TLR4 receptors [38–40], the different response
observed could be due to the different expression of these receptors
in PBM and THP-1 cells. CD14 is not expressed by THP-1
monocytes, but it is expressed by PBM. This fact could explain
why THP-1 cells produced a much smaller response to LPS than
PBM and also the difference of kinetics in the LPS induced TNF
secretion. The peak of TNF response was observed after 8 h
stimulation followed by a rapid decrease to baseline at 10 h,
whereas on THP-1 cells the peak was not reached until after 56 h.
Moreover, the amount of TNF secreted by monocytes induced
with dCGN was much larger than the one induced by LPS. On
the other hand, LPS and dCGN displayed a very different TNF
secretion curve in THP-1 cells. These differences suggest that
dCGN and LPS could use different activation mechanisms. It is
noteworthy that neutralizing antibody to CD14 only partially
(,40%) inhibited dCGN-induced TNF secretion (not shown).
TLR4 has been recently identified as a surface membrane receptor
for CGN in human colonic epithelial cells [41]. Thus, it is possible
that TLR4 is activated by dCGN to induce cytokine secretion by
monocytes. We can only speculate that TLR4 may have a higher
affinity-binding site for dCGN than for LPS, however, this
hypothesis remains to be tested.
Another indicator that dCGN stimulate monocytes leading to a
more active phenotype is the fact that surface expression of the
Figure 5. Degraded CGN induced monocytes aggregation in
vitro. Monocytes were incubated in the absence (A) or the presence of
1 mg/ml 10 kDa dCGN (B), 1 mg/ml 40 kDa dCGN (C), or 1 mg/ml 40
kDa dCGN plus 2.5 mg/ml anti-ICAM-1 antibody (D). Cells were
observed by phase contrast inverse microscopy at 150X magnification.
Inserts in A and B show a close up of cells at 300X magnification. E:
Number of monocyte aggregates in 24 wells plate of PBM cell cultured
with nothing (control), with 10 kDa degraded CGN (C10), or with 40 kDa
degraded CGN (C40). Some cultures had also 2.5 mg/ml anti-ICAM-1
antibody. Data are mean +/2 SEM.
doi:10.1371/journal.pone.0008666.g005
Figure 6. Degraded CGN stimulated ICAM-1 and TNF-a gene
expression in monocytes. Representative samples of RT-PCR analysis
showing over expression of ICAM-1 and TNF-a after stimulation of
monocytes with 1 g/l of degraded CGN. b-actin expression was used as
normalization gene.
doi:10.1371/journal.pone.0008666.g006
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cells.TheoverexpressionofICAM-1causedtheactivatedmonocytes
to form cell aggregates that were more abundant among cells treated
with the 40 kDa dCGN. This correlates with the higher expression of
ICAM-1 induced by the 40 kDa dCGN, suggesting that the partially
degraded CGN is more biologically active. In addition, the cell
aggregates are reminiscent of monocyte aggregates, which form
multinucleated giant cells (MGC) in patients with Crohn’s disease
[42]. These giant cells were not observed in healthy individuals or in
patients with ulcerative colitis [42]. Moreover, increased expression
levelsofICAM-1andLFA-3(CD58)werealsodetectedinmonocytes
from patients with Crohn’s disease [43,44]. Thus, degraded CGN
clearly can activate monocytes to express an increased number of
ICAM-1 adhesion molecules, therefore being capable of creating the
conditions characteristic of Crohn’s disease symptomatology, i.e.
PBM accumulation and MGC formation [45,46].
Figure 7. Degraded CGN activated the NF-kB pathway in monocytes. A: THP-1 cells were transfected with a NF-kB reporter plasmid driving
expression of luciferase. Cells were then treated with various concentrations of 10 kDa (triangles), or 40 kDa dCGN (squares). B: THP-1 cells treated
with 1 mg/ml of 10 kDa dCGN (C10), or with 1 mg/ml of 40 kDa dCGN (C40) were lysed after various periods of time. Proteins in cell extracts were
resolved by SDS-PAGE and then Western blotted for IkBa or a2tubulin as loading control. C: Degraded carrageenans (dCGN) induced activation of
NF-kB. THP-1 cells were treated with nothing (control), or with 1 mg/ml of 10 kDa dCGN (C10), or with 1 mg/ml of 40 kDa dCGN (C40) for 30 minutes
at 37uC. Nuclei were isolated and lysed. Proteins in nuclear extracts were resolved by SDS-PAGE and then Western blotted for NF-kB p50 subunit
(p50) or NF-kB p65 subunit (p65). Lower panels show Western blots of nuclear ERK revealing equivalent amount of protein in each sample. Data are
representative of three separate experiments. D: Degraded carrageenan (dCGN) induced activation of NF-kB. Nuclei isolated from THP-1 cells were
fluorescence-stained for NF-kB p50 subunit or NF-kB p65 subunit before (filled area) or after cells were treated with 1 mg/ml of 10 kDa dCGN (C10),
or with 1 mg/ml of 40 kDa dCGN (C40) for 30 minutes at 37uC. Dashed line corresponds to nuclei stained only with secondary fluorescence antibody.
Fluorescence intensity was analyzed by flow cytometry as described.
doi:10.1371/journal.pone.0008666.g007
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and TNF-a expression. NF-kB activation is associated with the
degradation of the inhibitor protein IkB [47]. Indeed, dCGN
induced NF-kB activation as shown by degradation of IkBa,
translocation of p65 and p50 sub-units to the nucleus and by
activation of an NF-kB-responsive luciferase reporter plasmid.
Again, a stronger activation of NF-kB was induced by the 40 kDa
dCGN compared to 10 kDa dCGN, suggesting that the partially
degraded CGN is more biologically active. Our data are in
agreement with a previous study showing that native CGN also
induced activation of NF-kB in human colonic epithelial cells [48].
NF-kB pathway is often associated to promote cell survival and
cancer cell growth, however it has been sometimes reported to
behave as a tumor suppressor, arresting cell proliferation [49].
Such relationship between NF-kB activation and cell cycle
regulation has been reported in normal human epidermal cells
[50]. Indeed, it has been shown that NF-kB activation suppressed
cdk4 expression, which is necessary for the transition to S phase.
Finally, NF-kB activation was reported to induce growth arrest in
normal human keratinocytes by a mechanims involving the cdk
inhibitor p21 [51]. The effects of dCGN on p21 and cdk4
expression remain to be studied.
In these studies, we have demonstrated a direct action of dCGN
on monocytes. Monocytes exposed to dCGN acquired an
inflammatory phenotype that included higher expression of the
adhesion molecule ICAM-1 and TNF-a production, via the NF-kB
pathway. This higher expression of ICAM-1 resulted in formation
of cell aggregates similar to those observed in patients with
Crohn’s disease. We presume that the differential effects of 10 and
40 kDa dCGN to induce these effects on monocytes are tightly
linked to their capacity to induce inflammation in vivo. However, in
vivo, macrophages do not come in direct contact with the intestinal
lumen and are separated by the epithelial barrier. The way by
which dCGN may leave the intestinal lumen and cross the
epithelial barrier to reach the macrophages is an intriguing open
question. One possible explanation resides in the potential of
dCGN to ‘‘induce’’ cellular and paracellular injurious effects at the
intestinal epithelial cell monolayer [48].
In conclusion, dCGN inhibited THP-1 cell proliferation in vitro,
accumulating the cells in the G1 phase of the cell cycle, increased
ICAM-1 expression, stimulated ICAM-1-dependent monocyte
aggregation in vitro, and stimulated TNF-a expression and
secretion. These responses were more pronounced following 40
kDa dCGN, and were all linked to NF-kB activation. These results
suggest that, although CGN is widely used as a food additive, its
degraded forms have an important effect on monocytes charac-
teristic of an inflammatory phenotype.
Acknowledgments
We thank Mihai Covasa and Timothy Swartz for revising the English
manuscript. We thank Martine Rival for helpful expertise in histology. We
thank Nancy Mora Perez for excellent technical assistance and Guadalupe
Diaz for performing the FACS measurements of NF-kB.
Author Contributions
Conceived and designed the experiments: CB CM JPS ML JPG CC HMB.
Performed the experiments: CB CM CR HMB. Analyzed the data: CB AC
CR JPS HMB. Wrote the paper: AC CM CR JPS HMB.
References
1. Stanley N (1987) Production, properties and use of carrageenans. In ‘‘Production
and utilization of products from commercial seaweeds’’. McHugh, D.J. (Ed),
FAO Fisheries Technical paper, Rome. pp 116–146.
2. Stanley NF (1990) Carrageenans. In ‘‘Foods Gels’’. Harris P. (Ed), Elsevier
Science Publishing Co., New York. pp 79–117.
3. Marcus R, Watt J (1971) Colonic ulceration in young rats fed with degraded
carrageenan. Lancet 2: 765–766.
4. Kitano A, Matsumoto T, Hiki M, Hashimura H, Yoshiyasu K, et al. (1986)
Epithelial dysplasia of the rabbit colon induced by degraded carrageenan.
Cancer Res 46: 1374–1376.
5. Marcus AJ, Marcus SN, Marcus R, Watt J (1989) Rapid production of ulcerative
disease of the colon in newly-weaned guinea-pigs by degraded carrageenan.
J Pharm Pharmacol 41: 423–426.
6. Tobacman JK (2001) Review of harmful gastrointestinal effects of carrageenan
in animal experiments. Environ Health Perspect 109: 983–994.
7. Cohen SM, Ito N (2002) A critical review of the toxicological effects of
carrageenan and processed eucheuma seaweed on the gastrointestinal tract. Crit
Rev Toxicol 32: 413–444.
8. Weiner ML, Nuber D, Blakemore WR, Harriman JF, Cohen SM (2007) A 90-
day dietary study on kappa carrageenan with emphasis on the gastrointestinal
tract. Food Chem Toxicol 45: 98–106.
9. Ekstrom LG, Kuivinem J, Johansson G (1983) Molecular weight distribution and
hydrolysis behaviour of carrageenans. Carbohydr Res 116: 89–94.
10. Ekstrom LG (1985) Molecular weight distribution and the behaviour of kappa-
carrageenan on hydrolysis. Carbohydr Res 135: 283–289.
11. Michel C, Macfarlane GT (1996) Digestive fates of soluble polysaccarides from
marine microalgae: involvement of the colonic microflora and physiological
consequences for the host. J Appl Bacteriol 80: 349–369.
12. Rochet V, Bernalier A (1997) Utilization of algal polysaccharides by human
colonic bacteria, in axenic culture or in association with hydrogenotrophic
microorganisms. Reprod Nutr Dev 37: 221–229.
13. Borthakur A, Bhattacharyya S, Dudeja PK, Tobacman JK (2007) Carrageenan
induces interlukin-8 production through distinct Bcl10 pathway in normal
human colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 292:
G829–G838.
14. Bhattacharyya S, Dudeja PK, Tobacman JK (2008) Carrageenan-induced NF-
kB activation depends on distinct pathways mediated by reactive oxygen species
and Hsp27 or by Bcl10. Bioch Bioph Acta 1780: 973–982.
15. Baeuerle PA, Baltimore D (1988) I kappa B: a specific inhibitor of the NF-kappa
B transcription factor. Science 242: 540–546.
16. Baeuerle P, Henkel T (1994) Function and activation of NF-kB in the immune
system. Annu Rev Immunol 12: 141–153.
17. Rugveit J, Nilsen EM, Bakka A, Carlsen H, Brandtzaeg P, et al. (1997) Cytokine
profiles differ in newly recruited and resident subset of mucosal macrophages
from inflammatory bowel disease. Gastroenterology 112: 1493–1505.
18. Kitsukawa Y, Saito H, Suzuki Y, Kasanuki J, Tamura Y, et al. (1992) Effect of
ingestion of eicosapentaenoic acid ethyl ester on carrageenan-induced colitis in
guinea pigs. Gastroenterology 102: 1859–66.
19. Elson CO, Sartor RB, Tennyson GS, Riddell RH (1995) Experimental models
of inflammatory bowel disease. Gastroenterology 109: 1344–67.
20. Axelsson LG, Landstrom E, Goldscmidt TJ, Gronberg A, Bylund-Fellenius AC
(1996) Dextran sulfate sodium (DSS) induced experimental colitis in immuno-
deficient mice: Effect in CD4+cell depleted, athymic and NK-cell depleted SCID
mice. Inflamm Res 45: 181–191.
21. Viebke C, Borgstro ¨m J, Piculell L (1995) Characterisation of kappa- and iota-
carrageenan coils and helices by MALLS/GPC. Carbohydr Polym 27: 145–154.
22. Quemener B, Lahaye M, Bobin-Dubigeon C (1997) Sugar determination in
ulvans by a chemical-enzymatic method coupled to high performance anion
exchange chromatography. J Appl Phycol 9: 179–188.
23. Van der Waaij D, Cohen BJ, Anver MR (1974) Mitigation of experimental
inflammation bowel disease in guinea pigs by selective elimination of the aerobic
gram-negative intestinal microflora. Gastroenterology 67: 460–472.
24. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Ingaki Y, et al. (1990) A
novel method in the induction of reliable experimental acute and chronic
ulcerative colitis in mice. Gastroenterology 98: 694–702.
25. Barbier M, Cherbut C, Aube ´ AC, Blottie `re HM, Galmiche JP (1998) Elevated
plasma leptin concentrations in early stages of experimental intestinal
inflammation in rats. Gut 43: 783–90.
26. Segain JP, Raingeard de la Ble ´tie `re D, Bourreille A, Leray V, Gervois N, et al.
(2000) Butyrate inhibits inflammatory responses through NFkB inhibition:
implications for Crohn’s disease. Gut 47: 397–403.
27. Krawisz JE, Sharon P, Stenson WF (1984) Quantitative assay for acute intestinal
inflammation based on myeloperoxidase activity. Assessment of inflammation in
rat and hamster models. Gastroenterology 87: 1344–1350.
28. Anegon I, Blottiere H, Cuturi MC, Lenne Y, Trinchieri G, et al. (1993)
Characterization of a human monocyte antigen, B148.4, regulated during cell
differentiation and activation. J Leukoc Biol 53: 390–398.
29. Espevik T, Nissen-Meyer J (1986) A highly sensitive cell line, WEHI 164 clone
13, for measuring cytotoxic factor/tumor necrosis factor from human
monocytes. J Immunol Methods 95: 99–105.
Carrageenan Activates Monocyte
PLoS ONE | www.plosone.org 10 January 2010 | Volume 5 | Issue 1 | e866630. Rosales C, Juliano R (1996) Integrin signaling to NF-kappa B in monocytic
leukemia cells is blocked by activated oncogenes. Cancer Res 56: 2302–2305.
31. Garcı ´a-Garcı ´a E, Rosales C (2007) Nuclear factor activation by FccR in human
peripheral blood neutrophils detected by a novel flow cytometry-based method.
J Immunol Meth 320: 104–118.
32. Garcı ´a-Garcı ´a E, Nieto-Castan ˜eda G, Ruiz-Saldan ˜a M, Mora N, Rosales C
(2009) FccRIIA and FccRIIIB mediate nuclear factor activation through
separate signaling pathways in human neuthophils. J Immunol 182: 4547–4556.
33. Podolsky D (2002) Inflammatory bowel disease. N Engl J Med 347: 417–429.
34. Alexander C, Rietschel ET (2001) Bacterial lipopolysaccharides and innate
immunity. J Endotoxin Res 7: 167–202.
35. Fiocchi C (1997) Intestinal inflammation: a complex interplay of immune and
non-immune cell interactions. Am J Physiol Gastrointest Liver Physiol 273:
G769–G775.
36. Nemeth ZH, Deitch EA, Szabo C, Hasko G (2002) Hyperosmotic stress induces
NF-kB activation and interlukin-8 production in human intestinal epithelial cells.
Am J Pathol 161: 987–996.
37. Bhattacharyya S, Borthakur A, Dudeja PK, Tobacman JK (2008) Carrageenan
induces cell cycle arrest in human intestinal epithelial cells in vitro. J Nutr 138:
469–475.
38. Guha M, Mackman N (2001) LPS induction of gene expression in human
monocytes. Cell Sign 13: 85–94.
39. Feng JM, Shi JQ, Liu JS (2003) The effect of lipopolysaccharides on the
expression of CD14 and TLR4 in rat Kuppfer cells. Hepatobiliary & Pancreatic
Diseases Intern 2: 265–269.
40. Lu YC, Yeh WC, Ohashi PS (2008) LPS/TLR4 signal transduction pathway.
Cytokine 42: 145–151.
41. Bhattacharyya S, Gill R, Chen ML, Zhang F, Linhardt R, et al. (2008) Toll-like
receptor 4 mediates induction of the Bcl10-NF-kB-Interleukin-8 inflammatory
pathway by carrageenan in human intestinal epithelial cells. J Biol Chem 283:
10550–10558.
42. Liu ZX, Noguchi M, Hitawatashi N, Toyota T (1996) Monocyte aggregation
and multinucleated giant-cell formation in vitro in Crohn’s disease.
Scand J Gastroenterol 31: 706–710.
43. Mishra L, Mishra B, Harris M, Bayless T, Muchmore A (1993) In vitro cell
aggregation and cell adhesion molecules in Crohn’s disease. Gastroenterology
104: 772–779.
44. Liu ZX, Hitawatashi N, Noguchi M, Toyota T (1997) Increased expression of
costimulatory on peripherical blood monocytes in patients with Crohn’s disease.
Scand J Gastroenterol 32: 1241–1246.
45. Grimm MC, Pullman WE, Bennett GM, Sullivan PJ, Pavli P, et al. (1995) Direct
evidence of monocyte recruitment to inflammatory bowel disease mucosa.
J Gastroenterol Hepatol 10: 387–395.
46. Miura M, Hiwatashi N (1987) Impaired monocyte macrophages function in
patients with Crohn’s disease. J Clin Lab Immunol 24: 167–170.
47. Jobin C, Sartor RB (2000) The I kappa B/NF-kappa B system: a key
determinant of mucosalinflammation and protection. Am J Physiol Cell Physiol
278: C451–62.
48. Ling KY, Bhalla D, Hollander D (1988) Mechanisms of carrageenan injury of
IEC18 small intestinal epithelial cell monolayers. Gastroenterology 95: 1487–95.
49. Perkins ND, Gilmore TD (2006) Good cop, bad cop: the different faces of NF-
kB. Cell Death Differ 13: 759–772.
50. Dajee M, Lazarov M, Zhang JY, Cai T, Green CL, Russell AJ, Marinkovich MP,
Tao S, Lin Q, Kubo Y, Khavari PA (2003) NF-kappaB blockade and oncogenic
Ras trigger invasive human epidermal neoplasia. Nature 421: 639–43.
51. Basile JR, Eichten A, Zacny V, Mu ¨nger K (2003) NF-kappaB-mediated
induction of p21(Cip1/Waf1) by tumor necrosis factor alpha induces growth
arrest and cytoprotection in normal human keratinocytes. Mol Cancer Res 1:
262–70.
Carrageenan Activates Monocyte
PLoS ONE | www.plosone.org 11 January 2010 | Volume 5 | Issue 1 | e8666